
MOMENTUM Examines Hypercortisolism in Hypertension with Deepak L. Bhatt, MD
Corcept Therapeutics signaled the launch of the MOMENTUM clinical trial to establish the prevalence of endogenous hypercortisolism (Cushing’s syndrome) in patients with resistant hypertension.1 Announced on March 10, 2025, the trial will enroll 1000 …